Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00239668 · ClinicalTrials.gov registry record
Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 3,000
- Enrollment target
NCT00239668: Completed study, sponsored by Massachusetts General Hospital.
NCT00239668 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 3,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00239668 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 3,000 participants
- Enrollment target
Study Summary
The purpose of this study is to establish an expected recovery trajectory (recovery model) in terms of physical and psychological function of the pediatric burn patient.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2000-03 |
| Est. Completion | 2013-01 |
What the finished NCT00239668 record still lists
NCT00239668 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00239668 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00239668 about?
NCT00239668 is a clinical study titled "Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors". The purpose of this study is to establish an expected recovery trajectory (recovery model) in terms of physical and psychological function of the pediatric burn patient.
What is the current status of trial NCT00239668?
This trial is currently completed. The enrollment target is 3,000 participants. The study started on 2000-03. Estimated completion is 2013-01.
Who is sponsoring clinical trial NCT00239668?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia